Luis Pérez de Llano

Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial

William W. Busse, Eugene R. Bleecker, J Mark FitzGerald et al. · The Lancet Respiratory Medicine · 2018 · 311 citations

Pharmacy, Pharmacology, Pharmacotherapy +6

Short-term and Long-term Effects of Nasal Intermittent Positive Pressure Ventilation in Patients With Obesity-Hypoventilation Syndrome

Luis Pérez de Llano, Rafael Golpe, Montserrat Ortiz Piquer et al. · CHEST Journal · 2005 · 273 citations

Medicine, Internal Medicine, Otolaryngology +15

EAACI Biologicals Guidelines—Recommendations for severe asthma

Ioana Agache, Cezmi A. Akdiş, Mübeccel Akdiş et al. · Allergy · 2020 · 273 citations · Full text

Pharmacy, Pharmacoeconomics, Pharmacotherapy +14

Eosinophilic and Noneosinophilic Asthma

Liam G. Heaney, Luis Pérez de Llano, Mona Al‐Ahmad et al. · CHEST Journal · 2021 · 265 citations · Full text

Life Sciences, Immunology, Internal Medicine +14

Obesity-Hypoventilation Syndrome: Increased Risk of Death over Sleep Apnea Syndrome

Olalla Castro‐Añón, Luis Pérez de Llano, Sandra de la Fuente Sánchez et al. · PLoS ONE · 2015 · 170 citations · Full text

Medicine, Internal Medicine, Pulmonology +8